Sign Up
OverviewAPI
The global plasma fractionation market is valued at $5 billion in 2023, with the United States dominating plasma donation centers and supplying 70% of plasma for therapies. Major players include Baxter, Grifols, Kedrion, Octapharma, CSL, and Takeda. Recent developments involve new plants and partnerships. Dedicated individuals like Mark and Erik emphasize the importance of plasma donations, while studies highlight the benefits of products like Omniplasma in medical procedures.

Ask a question